Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Buccal Film (DBF) in Pediatric, Adolescent and Adult Subjects With Epilepsy

NCT03428360 is registered in ClinicalTrials.gov with Aquestive Therapeutics as lead sponsor.

NCT NCT03428360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03428360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Buccal Film (DBF) in Pediatric, Adolescent and Adult Subjects With Epilepsy
Lead sponsor
Aquestive Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
January 23, 2018
Completion date
June 25, 2020
Enrollment
149 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy